Gastrointestinal adverse events of immunotherapy

Cancer immunotherapy with immune-checkpoint inhibitors (ICIs) has emerged as an effective treatment for different types of cancer. ICIs are monoclonal antibodies that inhibit the signaling pathway that suppress antitumor T-cell activity. Patients benefit from increased overall and progression-free s...

Descripción completa

Detalles Bibliográficos
Autores principales: Cappello, Giovanni, Molea, Francesca, Campanella, Delia, Galioto, Francesca, Russo, Filippo, Regge, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Institute of Radiology. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185848/
https://www.ncbi.nlm.nih.gov/pubmed/35707753
http://dx.doi.org/10.1259/bjro.20210027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185848/
https://www.ncbi.nlm.nih.gov/pubmed/35707753
http://dx.doi.org/10.1259/bjro.20210027

Ejemplares similares